HomeLIVN • NASDAQ
add
LivaNova PLC
Previous close
$63.53
Day range
$61.47 - $63.87
Year range
$32.48 - $71.92
Market cap
3.40B USD
Avg Volume
931.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 360.92M | 12.15% |
Operating expense | 194.07M | 16.00% |
Net income | 30.91M | -44.70% |
Net profit margin | 8.56 | -50.72% |
Earnings per share | 0.86 | 6.17% |
EBITDA | 58.88M | -0.28% |
Effective tax rate | -11.88% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 635.55M | 48.20% |
Total assets | 2.61B | 3.98% |
Total liabilities | 1.41B | 18.54% |
Total equity | 1.20B | — |
Shares outstanding | 54.69M | — |
Price to book | 2.89 | — |
Return on assets | 4.53% | — |
Return on capital | 7.14% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 30.91M | -44.70% |
Cash from operations | 82.40M | 4.69% |
Cash from investing | -30.26M | -182.58% |
Cash from financing | -62.88M | -1,725.90% |
Net change in cash | -10.53M | -118.47% |
Free cash flow | 39.80M | -58.51% |
About
LivaNova, plc is a medical device manufacturer that is a foreign domiciled company based in the U.K. for tax inversion purposes. With operational headquarters in the United States. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN". Wikipedia
Founded
1987
Website
Employees
3,300
